Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study

脑蛋白水解物辅助治疗可改善肌萎缩侧索硬化症（ALS）患者的临床症状：一项前瞻性、单中心、安慰剂对照、随机、双盲 II 期研究的结果